Post Inflammatory Hyperpigmentation, or PIH for short, is a common skin condition that affects millions of people worldwide. It's characterized by dark patches on the skin that develop after an injury, inflammation, or acne breakout. While it doesn't pose any serious health risks, PIH can be frustrating and embarrassing for those who experience it. Fortunately, there are several effective treatments available to help diminish these unsightly marks and improve the overall appearance of your skin. So if you're a medical professional looking to understand more about post inflammatory hyperpigmentation causes and treatments - keep reading!
Post Inflammatory Hyperpigmentation (PIH) is a type of hyperpigmentation that occurs as a result of skin inflammation or injury. It's a common condition, particularly among people with darker skin tones. PIH manifests as flat, dark patches on the skin that are either brown, black or red in color.
The primary cause of PIH is an overproduction of melanin - the pigment responsible for giving our skin its color. When the body detects an injury or inflammation to the skin, it produces more melanin than usual to help protect and heal damaged cells. This excess melanin can accumulate in certain areas and create dark patches.
Some conditions that can lead to PIH include acne breakouts, eczema, psoriasis, insect bites and burns. Even something as simple as scratching your skin too hard can trigger PIH.
Post inflammatory hyperpigmentation (PIH) is a common skin condition that occurs as a result of various underlying causes. The primary cause of PIH is inflammation, which triggers an overproduction of melanin in the affected area.
One common trigger for PIH is acne, which can leave behind dark spots on the skin long after the pimples have cleared up. Other possible causes include injuries or wounds, such as cuts or burns, and certain medical conditions like eczema and psoriasis.
In some cases, medications may also contribute to post-inflammatory hyperpigmentation. Certain drugs like antimalarials and chemotherapy agents are known to increase pigmentation levels in some individuals.
Furthermore, people with darker skin tones are more likely to experience PIH due to their increased production of melanin. Hormonal changes during pregnancy or with oral contraceptive use can also lead to excess pigment production and subsequent hyperpigmentation.
Treatments for Post Inflammatory Hyperpigmentation (PIH) vary depending on the severity of the condition. Mild cases can be treated with over-the-counter creams that contain ingredients like hydroquinone, kojic acid, or retinoids which work by blocking melanin production and promoting skin cell turnover. These topical treatments are usually effective in lightening dark spots caused by PIH.
For moderate to severe cases, dermatologists may recommend more aggressive treatment options such as chemical peels, microdermabrasion or laser therapy. Chemical peels involve applying a solution containing acids to exfoliate the top layers of the skin while microdermabrasion uses tiny crystals to remove dead skin cells.
Laser therapy uses intense pulses of light to target pigmented areas which helps break up melanin clusters and stimulate collagen production resulting in improved texture and tone. However, these treatments require multiple sessions and come at a higher cost than topical creams.
Post inflammatory hyperpigmentation is a common skin condition that affects many people of all ages and skin types. It can result from various causes, including acne, eczema, psoriasis, and other medical conditions.
Fortunately, there are several treatments available for post inflammatory hyperpigmentation. These include topical creams containing hydroquinone or retinoids, chemical peels, microdermabrasion and laser therapy.
If you're experiencing post inflammatory hyperpigmentation or any other skin concerns, consult with a dermatologist who can help determine the best treatment plan for your individual needs. With proper care and treatment, you can achieve clear and healthy-looking skin once again.
1.
A three-quarters reduction in the risk of prostate cancer is associated with an annual increase in cardiorespiratory fitness of more than three percent.
2.
Study Homes In on Simpler Lung Cancer Screening Criteria
3.
Novel analysis identifies markers that may predict failure of metastatic prostate cancer treatment
4.
No Survival Bump in Metastatic NSCLC With Addition of ADC to Immunotherapy
5.
More Positive Survival Data in Lung Cancer With Perioperative Therapy
1.
Bone Marrow Microenvironment Biomarkers in Hematologic Health
2.
Emerging Insights in Hematology for Better Care
3.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
4.
Radioligand Therapy Advances: PSMA, Neuroendocrine, and Solid Tumor Clinical Insights
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Expert Perspectives on Hematology
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
3.
How Multidisciplinary Teams Support Modern Cancer Care
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
5.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation